4.
91例局限期SCLC的总生存期的单因素分析
Single factor analysis of overall survival in 91 Limited-disease SCLC patients
| Factors | Number (n=91) | Median survival time (mo) | P |
| Sex | 0.629 | ||
| Male | 60 | 19.9 | |
| Female | 31 | 18.8 | |
| Age (yr) | 0.528 | ||
| < 70 | 85 | 19.3 | |
| ≥70 | 6 | 21.1 | |
| PS | 0.192 | ||
| 0 | 18 | 21.1 | |
| 1 | 68 | 19.7 | |
| 2 | 5 | 11.8 | |
| Stage | < 0.001 | ||
| Ⅰ | 17 | 30.4 | |
| Ⅱ | 15 | 22.7 | |
| Ⅲa | 41 | 16.0 | |
| Ⅲb期 | 18 | 15.3 | |
| Sodium (Na) in baseline | 0.236 | ||
| Normal | 78 | 20.0 | |
| Low | 13 | 16.1 | |
| NSE in baseline | 0.672 | ||
| Normal | 34 | 20.2 | |
| High | 57 | 19.2 | |
| Radiation mode | 0.011 | ||
| Conventional radiotherapy | 30 | 22.7 | |
| Dimensional conformal radiation therapy | 51 | 19.3 | |
| Intensity modulated radiation therapy | 10 | 11.7 | |
| Chemotherapy prior radiation therapy | 0.024 | ||
| 1-2 cycles | 35 | 16.5 | |
| 3-4 cycles | 56 | 21.5 | |
| Preventive whole brain radiotherapy | 22 | 0.940 | |
| Yes | 19.4 | ||
| No | 19.6 |